Package 68462-583-11

{"route": ["ORAL"], "spl_id": "41f97256-ac39-413d-8b2f-5fb7ad429143", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "upc": ["0368462585764", "0368462112335", "0368462584767", "0368462583401"], "unii": ["1NF15YR6UY"], "rxcui": ["403810", "403811", "644088", "754508"], "spl_set_id": ["d72e0e10-4557-41b0-b65d-d395468cad19"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (68462-583-11)  / 10 CAPSULE in 1 BLISTER PACK", "package_ndc": "68462-583-11", "marketing_start_date": "20171012"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (68462-583-40)  / 1 CAPSULE in 1 BLISTER PACK", "package_ndc": "68462-583-40", "marketing_start_date": "20171012"}, {"sample": false, "description": "5 BLISTER PACK in 1 CARTON (68462-583-85)  / 1 CAPSULE in 1 BLISTER PACK", "package_ndc": "68462-583-85", "marketing_start_date": "20171012"}], "brand_name": "Aprepitant", "product_id": "68462-583_41f97256-ac39-413d-8b2f-5fb7ad429143", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "68462-583", "generic_name": "Aprepitant", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aprepitant", "active_ingredients": [{"name": "APREPITANT", "strength": "40 mg/1"}], "application_number": "ANDA207777", "marketing_category": "ANDA", "marketing_start_date": "20171012", "listing_expiration_date": "20271231"}